Benzocaine orally dissolvable strips - Oak Therapeutics
Latest Information Update: 28 Oct 2021
At a glance
- Originator Oak Therapeutics
- Class Aminobenzoic acids; Benzoates; Local anaesthetics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Oct 2021 No recent reports of development identified for preclinical development in Pain in USA (PO, Film)
- 04 Sep 2017 Preclinical trials in Pain in USA (PO) (Oak Therapeutics pipeline, September 2017)